Sinopharm Group Co. Ltd. (ADR)
General ticker "SHTDY" information:
- Sector: Health Care
- Industry: Medical - Distribution
- Capitalization: $9.3B (TTM average)
Sinopharm Group Co. Ltd. (ADR) follows the US Stock Market performance with the rate: 17.6%.
Estimated limits based on current volatility of 0.9%: low 12.84$, high 13.08$
Factors to consider:
- Company pays dividends (irregularly): last record date 2025-06-17, amount 0.47$ (Y3.62%)
- Price in estimated range
- Earnings for 18 months up through Q2 (+1 year) exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [10.73$, 16.21$]
- 2024-12-30 to 2025-12-30 estimated range: [10.69$, 16.40$]
Financial Metrics affecting the SHTDY estimates:
- Positive: with PPE of 30.3 at the end of fiscal year the price was very low
- Positive: -3.60 < Operating profit margin, % of 3.39
- Positive: Operating cash flow per share per price, % of 31.33 > 13.24
- Positive: 1.87 < Return on assets ratio (scaled to [-100,100]) of 2.31
- Negative: Industry operating cash flow per share per price (median), % of 4.13 <= 5.52
- Positive: -8.75 < Industry operating profit margin (median), % of 0.46
- Negative: Industry earnings per price (median), % of 2.85 <= 4.43
- Negative: 18.93 < Shareholder equity ratio, % of 19.45 <= 41.86
Short-term SHTDY quotes
Long-term SHTDY plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | CNY552,147.55MM | CNY596,569.56MM | CNY584,507.93MM |
| Operating Expenses | CNY531,543.08MM | CNY576,360.37MM | CNY568,319.53MM |
| Operating Income | CNY20,604.47MM | CNY20,209.19MM | CNY16,188.40MM |
| Non-Operating Income | CNY-2,040.65MM | CNY-697.06MM | CNY-2,187.50MM |
| Interest Expense | CNY3,520.33MM | CNY2,956.59MM | CNY2,734.04MM |
| Income(Loss) | CNY18,563.82MM | CNY19,512.14MM | CNY14,000.90MM |
| Taxes | CNY4,218.38MM | CNY4,502.31MM | CNY3,577.30MM |
| Profit(Loss)* | CNY8,525.66MM | CNY9,053.76MM | CNY7,049.68MM |
| Stockholders Equity | CNY68,068.56MM | CNY74,582.22MM | CNY78,883.79MM |
| Inventory | CNY60,925.83MM | CNY60,027.65MM | CNY62,352.81MM |
| Assets | CNY364,775.13MM | CNY383,394.84MM | CNY392,831.24MM |
| Operating Cash Flow | CNY20,963.79MM | CNY17,173.03MM | CNY11,546.01MM |
| Capital expenditure | CNY2,417.53MM | CNY2,335.85MM | CNY1,968.08MM |
| Investing Cash Flow | CNY-3,589.62MM | CNY-944.53MM | CNY-3,750.93MM |
| Financing Cash Flow | CNY-5,693.48MM | CNY-7,643.97MM | CNY-17,285.03MM |
| Earnings Per Share** | CNY13.66 | CNY14.51 | CNY11.30 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.